Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 2,379 $ 454
Operating expenses:    
Research and development 14,569 12,562
General and administrative 5,149 4,865
Total operating expenses 19,718 17,427
Loss from operations (17,339) (16,973)
Other income, net 113 512
Net loss applicable to common stockholders $ (17,226) $ (16,461)
Net loss per share applicable to common stockholders - basic and diluted $ (0.39) $ (0.49)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic and diluted 43,923,999 33,766,333